| EQIX |
Report |
Total Revenue (Q2 2026) |
BEAT |
pred ~$2.63B vs. cons ~$2.595B |
MEDIUM |
| EQIX |
Report |
AFFO per share (Q2 2026) |
BEAT |
pred ~$11.40 vs. cons ~$11.25 |
MEDIUM |
| EQIX |
Report |
Normalized/CC Recurring Revenue Growth YoY (Q2 2026) |
IN-LINE |
pred ~10.8% vs. cons ~10.5% |
LOW |
| EQIX |
Guide |
FY2026 Revenue Guidance |
BETTER |
guide ~$10.24B (midpoint) vs. cons ~$10.19B (FY2026) |
MEDIUM |
| EQIX |
Guide |
FY2026 AFFO Guidance |
BETTER |
guide ~$4.30B vs. cons ~$4.24B (FY2026) |
MEDIUM |
| EQIX |
Guide |
Q3 2026 Revenue Guidance |
BETTER |
guide ~$2.66B vs. cons ~$2.62B (Q3 2026) |
LOW |
| EQIX |
Guide |
FY2026 Churn Guidance |
UNCHANGED |
guide ~2.0-2.5% vs. cons ~2.2% (FY2026) |
MEDIUM |
| EQIX |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.5% |
— |
MEDIUM |
| EQIX |
Return |
5-day cumulative residual |
+0.4% (FADE) |
Headline Q2 beat is largely explained by the previously-flagged Hampton xScale lease timing shift (already embedded in guidance with no full-year impact), so the 'beat' is mechanically expected rather than organic upside. With FY2026 revenue/AFFO guidance left roughly unchanged (just reaffirmed/nudged), implied H2 organic growth must decelerate to hit the full-year bar, which typically triggers analysts trimming out-quarter (Q3/Q4) estimates even after a Q2 beat. Combined with ongoing AI-capex overbuild skepticism weighing on data-center/semis peers, an initial positive pop is likely to partially fade over the following days as the 'quality of beat' narrative sets in and sell-side models normalize for the pulled-forward revenue. |
MEDIUM |